Early biomarkers from dynamic contrast-enhanced magnetic resonance imaging to predict the response to antiangiogenic therapy in high-grade gliomas
出版年份 2015 全文链接
标题
Early biomarkers from dynamic contrast-enhanced magnetic resonance imaging to predict the response to antiangiogenic therapy in high-grade gliomas
作者
关键词
High-grade glioma, Bevacizumab, Perfusion MRI, DCE MRI, Quantitative image analysis
出版物
NEURORADIOLOGY
Volume 57, Issue 12, Pages 1269-1280
出版商
Springer Nature
发表日期
2015-09-12
DOI
10.1007/s00234-015-1582-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Treatment Response Evaluation Using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy
- (2014) J. Schwarzenberg et al. CLINICAL CANCER RESEARCH
- Bevacizumab for the treatment of high-grade glioma: an update after Phase III trials
- (2014) Mustafa Khasraw et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Evaluation of dynamic contrast-enhanced MRI derived microvascular permeability in recurrent glioblastoma treated with bevacizumab
- (2014) Philipp Kickingereder et al. JOURNAL OF NEURO-ONCOLOGY
- Classification of tumor area using combined DCE and DSC MRI in patients with glioblastoma
- (2014) Moran Artzi et al. JOURNAL OF NEURO-ONCOLOGY
- Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
- (2014) Walter Taal et al. LANCET ONCOLOGY
- MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy
- (2014) Shahrzad Jalali et al. NEURO-ONCOLOGY
- Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma
- (2014) K. M. Schmainda et al. NEURO-ONCOLOGY
- Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma
- (2013) B. M. Ellingson et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Molecular pathogenesis of endometrial cancers in patients with Lynch syndrome
- (2013) Marilyn Huang et al. CANCER
- Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)
- (2013) Riccardo Soffietti et al. JOURNAL OF NEURO-ONCOLOGY
- Quantitative analysis of neovascular permeability in glioma by dynamic contrast-enhanced MR imaging
- (2012) Zhongzheng Jia et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Early perfusion changes in patients with recurrent high-grade brain tumor treated with Bevacizumab: preliminary results by a quantitative evaluation
- (2012) Antonello Vidiri et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- 3D Slicer as an image computing platform for the Quantitative Imaging Network
- (2012) Andriy Fedorov et al. MAGNETIC RESONANCE IMAGING
- Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies
- (2012) James P. B. O'Connor et al. Nature Reviews Clinical Oncology
- Antiangiogenic Therapy for Primary Liver Cancer: Correlation of Changes in Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Tissue Hypoxia Markers and Clinical Response
- (2011) Adam C. Yopp et al. ANNALS OF SURGICAL ONCOLOGY
- Reducing intratumour acute hypoxia through bevacizumab treatment, referring to the response of quiescent tumour cells and metastatic potential
- (2011) S Masunaga et al. BRITISH JOURNAL OF RADIOLOGY
- Glycolytic Phenotype and AMP Kinase Modify the Pathologic Response of Tumor Xenografts to VEGF Neutralization
- (2011) G. Nardo et al. CANCER RESEARCH
- Computed Tomography Perfusion Imaging for Therapeutic Assessment
- (2011) Vicky Goh et al. INVESTIGATIVE RADIOLOGY
- Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
- (2011) J. F. de Groot et al. NEURO-ONCOLOGY
- Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab
- (2011) B. M. Ellingson et al. NEURO-ONCOLOGY
- Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a 31P/1H MRSI and quantitative magnetic resonance imaging study
- (2011) E. Hattingen et al. NEURO-ONCOLOGY
- Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma
- (2010) J. J. C. Verhoeff et al. ANNALS OF ONCOLOGY
- Bevacizumab plus Fotemustine as First-line Treatment in Metastatic Melanoma Patients: Clinical Activity and Modulation of Angiogenesis and Lymphangiogenesis Factors
- (2010) M. Del Vecchio et al. CLINICAL CANCER RESEARCH
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma
- (2010) E. Essock-Burns et al. NEURO-ONCOLOGY
- ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma
- (2010) Martha Nowosielski et al. NEURORADIOLOGY
- Glioblastoma: A Method for Predicting Response to Antiangiogenic Chemotherapy by Using MR Perfusion Imaging—Pilot Study
- (2010) Rahul N. Sawlani et al. RADIOLOGY
- Enhancing Fraction in Glioma and Its Relationship to the Tumoral Vascular Microenvironment: A Dynamic Contrast-Enhanced MR Imaging Study
- (2009) S.J. Mills et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
- (2009) A. Gregory Sorensen et al. CANCER RESEARCH
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment
- (2009) Whitney B. Pope et al. RADIOLOGY
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started